Clinical Trial Update: Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART. [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing post-prandial lipid effects of raltegravir versus ritonavir-boosted darunavir in ART-naive or ART-recommencing adults with HIV (and ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)
• darunavir/ritonavir (darunavir/ritonavir)

Snippet

Sponsor: St Vincent's Hospital, Sydney | Conditions: HIV, Cardiovascular Disease | Phase 4 | Status: COMPLETED